Abbott India Limited, a subsidiary of Abbott Laboratories, is a leading pharmaceutical company in India offering a wide range of high-quality medicines in various therapeutic categories with a focus on product development and clinical support.

Abbott India major competitors are Alkem Laboratories, Aurobindo Pharma, Glenmark Pharma, Lupin, Glaxosmithkline Phar, Zydus Lifesciences, Ipca Laboratories.
Market Cap of Abbott India is ₹68,151 Crs.
While the median market cap of its peers are ₹59,689 Crs.

Abbott India seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.